Low-dose rivaroxaban plus aspirin for elderly patients with symptomatic peripheral artery disease: is it worth the bleeding risk?

European Heart Journal

3 September 2021
Organised by: Logo
ESC Journals DISEASES OF THE AORTA, PERIPHERAL VASCULAR DISEASE, STROKE Peripheral Vascular and Cerebrovascular Disease

Contributors

Gregory Y H Lip
Gregory Y H Lip

Author

University of Liverpool Liverpool , United Kingdom of Great Britain & Northern Ireland